TuHURA Biosciences, Inc.
HURA
$2.16
-$0.43-16.60%
NASDAQ
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -1.75% | 32.78% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -10.29% | 24.73% | |||
| Operating Income | 10.29% | -24.73% | |||
| Income Before Tax | -11.47% | 4.80% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -11.47% | 4.80% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -11.47% | 4.80% | |||
| EBIT | 10.29% | -24.73% | |||
| EBITDA | 10.33% | -24.79% | |||
| EPS Basic | 1.57% | 8.99% | |||
| Normalized Basic EPS | 24.52% | -24.25% | |||
| EPS Diluted | 1.57% | 8.99% | |||
| Normalized Diluted EPS | 24.52% | -24.25% | |||
| Average Basic Shares Outstanding | 13.22% | 4.61% | |||
| Average Diluted Shares Outstanding | 13.22% | 4.61% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | 0.10% | -0.05% | |||